ask="5.90"
ask_size="200"
average_daily_volume="77561"
bid="5.60"
bid_size="900"
book_value="5.08"
change="+0.38"
change_from_200_day_moving_average="-0.03"
change_from_50_day_moving_average="0.93"
change_from_52_week_high="-7.15"
change_From_52_week_low="1.94"
change_in_percent="+7.28%"
close="5.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-20.26M"
eps_estimate_current_year="-8.61"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="6404000"
high="5.67"
high_52_weeks="12.75"
last_trade_date="2/21/2017"
last_trade_price="5.60"
last_trade_size="176"
last_trade_time="4:00pm"
low="5.16"
low_52_weeks="3.66"
market_capitalization="75.21M"
moving_average_200_day="5.63"
moving_average_50_day="4.67"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="17.00"
open="5.22"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-0.50%"
percent_change_from_50_day_moving_average="+20.02%"
percent_change_from_52_week_high="-56.08%"
percent_change_from_52_week_low="+53.01%"
previous_close="5.22"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.03"
price_per_sales="14.12"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="2.04"
stock_exchange="NGM"
symbol="AGLE"
volume="113441"
weeks_range_52="3.66 - 12.75"
